Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 36, 2023 - Issue 2
Submit an article Journal homepage
105
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Successful treatment of sclerosing mesenteritis with tamoxifen monotherapy

Lauren Zammerilla Westcotta Department of Surgery, Baylor University Medical Center, Dallas, TexasCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4776-2745
, MDORCID Icon,
Dallas Wolforda Department of Surgery, Baylor University Medical Center, Dallas, Texas
, MD,
Taylor G. Maloneyb Department of Radiology, Baylor University Medical Center, Dallas, Texas
, MD &
Ronald C. Jonesa Department of Surgery, Baylor University Medical Center, Dallas, Texas
, MD
Pages 231-233 | Received 08 Sep 2022, Accepted 22 Nov 2022, Published online: 06 Dec 2022

  • Akram S, Pardi DS, Schaffner JA, Smyrk TC. Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol. 2007;5(5):589–596. quiz 523-4. doi:10.1016/j.cgh.2007.02.032.
  • Danford CJ, Lin SC, Wolf JL. Sclerosing mesenteritis. Am J Gastroenterol. 2019;114(6):867–873. doi:10.14309/ajg.0000000000000167.
  • McLaughlin PD, Filippone A, Maher MM. The "misty mesentery": mesenteric panniculitis and its mimics. AJR Am J Roentgenol. 2013;200(2):W116–W123. doi:10.2214/AJR.12.8493.
  • Clark CP, Vanderpool D, Preskitt JT. The response of retroperitoneal fibrosis to tamoxifen. Surgery. 1991;109(4):502–506.
  • Brandt AS, Kamper L, Kukuk S, Haage P, Roth S. Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Urol Int. 2014;93(3):320–325. doi:10.1159/000357814.
  • van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144(2):101–106. doi:10.7326/0003-4819-144-2-200601170-00007.
  • van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2013;24(5):444–450. doi:10.1016/j.ejim.2012.11.010.
  • van der Bilt FE, Hendriksz TR, van der Meijden WA, Brilman LG, van Bommel EF. Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy. Clin Kidney J. 2016;9(2):184–191. doi:10.1093/ckj/sfv148.
  • Venkataramani A, Behling CA, Lyche KD. Sclerosing mesenteritis: an unusual cause of abdominal pain in an HIV-positive patient. Am J Gastroenterol. 1997;92(6):1059–1060.
  • Emory TS, Monihan JM, Carr NJ, Sobin LH. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol. 1997;21(4):392–398. doi:10.1097/00000478-199704000-00004.
  • Mindelzun RE, Jeffrey RB, Jr., Lane MJ, Silverman PM. The misty mesentery on CT: differential diagnosis. AJR Am J Roentgenol. 1996;167(1):61–65. doi:10.2214/ajr.167.1.8659422.
  • Danford CJ, Lin SC, Smith MP, Wolf JL. Encapsulating peritoneal sclerosis. World J Gastroenterol. 2018;24(28):3101–3111. doi:10.3748/wjg.v24.i28.3101.
  • Vaglio A, Palmisano A, Alberici F, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011;378(9788):338–346. doi:10.1016/S0140-6736(11)60934-3.
  • Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005;97(22):1652–1662. doi:10.1093/jnci/dji372.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.